Laron

Nicola Mining Provides Exploration Update Including Results from Recently Completed ZTEM Survey

Retrieved on: 
Tuesday, September 13, 2022
Titan, EW, Property, 3D, Mining, FSE, Company, WP, News, Gold, ENE, See, TSX Venture Exchange, Teck Resources, SW, Blockchain.com, MYAB, Laron, Craigmont, National instrument, 2D, Uranium, Medical imaging, Rail transport, Highland Valley Copper mine, Earth, WNW, Central British Columbia Mountain forests

The Z-axis Tipper Electromagnetic ("ZTEM") survey has imaged the electrical conductivity signature of known mineral occurrences ("MINFILEs1") in the province of British Columbia.

Key Points: 
  • The Z-axis Tipper Electromagnetic ("ZTEM") survey has imaged the electrical conductivity signature of known mineral occurrences ("MINFILEs1") in the province of British Columbia.
  • ZTEM has produced similar comparable signatures in other locations within the district of the Property.
  • The Company is continuing data compilation and interpretation to better refine targets for a drilling exploration program upon receipt of the multi-year area-based ("MYAB1") exploration permit.
  • A 1,029 line-kilometre ZTEM survey was completed across a 184 square kilometre block covering the New Craigmont Property.

Global Laron Syndrome (LS) Pipeline Landscape Insights Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 2, 2020
Pharmaceutical, Health, Other Health, Medicine, Medical terminology, Health, Articles, Laron syndrome, Laron, Drug pipeline, Syndrome, Disease

The "Laron Syndrome (LS) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Laron Syndrome (LS) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report outlays comprehensive insights of present clinical development scenario and growth prospects across the Laron Syndrome (LS) market.
  • A detailed picture of the Laron Syndrome (LS) pipeline landscape is provided, which includes the disease overview and Laron Syndrome (LS) treatment guidelines.
  • The assessment part of the report embraces in-depth Laron Syndrome (LS) commercial assessment and clinical assessment of the Laron Syndrome (LS) pipeline products from the pre-clinical developmental phase to the marketed phase.